PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

mexiletine Side Effects

The reactions most often reported to the FDA for mexiletine (also sold as Mexitil), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

408
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of mexiletine come from 408 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 408 reports to the FDA Adverse Event Reporting System (FAERS) for mexiletine (Mexitil): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

408

Reports Mentioning Death

75

18.4% of reports — not proof the medicine caused the death

Hospitalizations

253

62.0% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

FATIGUE
31
VENTRICULAR TACHYCARDIA
31
DYSPNOEA
26
NAUSEA
24
POOR QUALITY SLEEP
24
IMPAIRED WORK ABILITY
23
IMPAIRED QUALITY OF LIFE
22
PYREXIA
22
CARDIAC FAILURE
18
HYPERTENSION
18
PNEUMONIA
18
CONTUSION
15
ALANINE AMINOTRANSFERASE INCREASED
14
CARDIAC FAILURE CONGESTIVE
14
DIARRHOEA
14
DIZZINESS
14
HERPES ZOSTER
14
RESPIRATORY FAILURE
14
CATARACT
13

Who Reports Side Effects

Gender Distribution

Female 158 (41%)
Male 230 (59%)
Unknown 1

Age Distribution

0-17 15 (5%)
18-44 24 (7%)
45-64 97 (30%)
65-74 82 (25%)
75+ 107 (33%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 75 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
PNEUMONIA 11
DEATH 10
CARDIAC ARREST 8
CARDIAC FAILURE 8
NAUSEA 8
CARDIAC FAILURE CONGESTIVE 7
PAIN 7
DYSPNOEA 6
RENAL FAILURE 6
THROMBOCYTOPENIA 6
VOMITING 6
ANAEMIA 5
ANXIETY 5
ECONOMIC PROBLEM 5
GENERAL PHYSICAL HEALTH DETERIORATION 5
RESPIRATORY FAILURE 5
VENTRICULAR TACHYCARDIA 5
ASTHENIA 4
HEADACHE 4
HYPERTENSION 4

Reactions in Hospitalization Reports

Top reactions in 253 reports where hospitalization was an outcome.

Reaction Reports
FATIGUE 31
POOR QUALITY SLEEP 24
IMPAIRED WORK ABILITY 23
IMPAIRED QUALITY OF LIFE 22
DYSPNOEA 20
VENTRICULAR TACHYCARDIA 20
PYREXIA 18
HYPERTENSION 17
PNEUMONIA 15
CONTUSION 13
HERPES ZOSTER 13
NAUSEA 13
CARDIAC FAILURE 12
CARDIAC FAILURE CONGESTIVE 12
CATARACT 12
INSOMNIA 12
RESPIRATORY FAILURE 12
WEIGHT INCREASED 12
ALANINE AMINOTRANSFERASE INCREASED 11

Compare mexiletine vs adenosine →

What the FAERS Data Reveals About mexiletine Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 408 voluntary reports linked to mexiletine and its brand equivalents (Mexitil), spanning 2004 through 2025. Of those, 75 (18.4%) listed death as an outcome and 253 (62.0%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 41% were female and 59% male; age distribution skews toward 75+, with 107 reports in that bracket. The single most reported reaction is fatigue with 31 submissions, followed by ventricular tachycardia and dyspnoea.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.

Drugs With a Similar FAERS Report Volume

Other medications with a total FDA adverse-event report count closest to mexiletine's 408.